Skip to main content
PsyBio Therapeutics Corp. logo

PsyBio Therapeutics Corp. — Investor Relations & Filings

Ticker · PSYBF ISIN · CA74464R1000 LEI · 549300KO32JSWBZIZP18 TSXV Manufacturing
Open in API
Filings indexed 249 across all filing types
Latest filing 2021-03-02 Interim / Quarterly Rep…
Country CA Canada
Listing TSXV PSYBF

About PsyBio Therapeutics Corp.

www.psybiolife.com

PsyBio Therapeutics Corp. is an intellectual property-driven biotechnology company focused on the discovery, design, and development of psycho-targeted therapeutics for mental and neurological conditions, including CNS disorders. The company develops a portfolio of novel psychoactive compounds and their analogues. A key differentiator is its proprietary platform utilizing genetically modified bacteria for the scalable, biosynthetic manufacturing of psychoactive molecules, such as tryptamines. PsyBio is actively engaged in preclinical studies and developing its own compounds, aiming to improve treatments for various psychologic and neurologic conditions.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM CONDENSED FINANCIAL STATEMENTS' for PsyBio Therapeutics Corp. for the three and six months ended December 31, 2020. It contains unaudited interim financial statements including statements of financial position, comprehensive loss, changes in equity, cash flows, and notes to the interim condensed financial statements. The document explicitly states it is prepared in accordance with International Accounting Standard 34, Interim Financial Reporting, which governs interim reports. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. There is no indication that this is an annual report or a full year report, but rather a report for a period shorter than a full fiscal year (quarterly or half-year). Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-03-02 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by PsyBio Therapeutics Corp. It details a significant corporate event: the completion of a reverse takeover transaction, including changes in company structure, share classifications, and management. The document references regulatory compliance with the TSX Venture Exchange and Canadian securities regulations (NI 51-102). It includes detailed descriptions of the transaction, share issuances, management appointments, and related corporate actions. This type of filing is a material change report, which is a regulatory disclosure of a significant event affecting the company, but it is not a full annual or quarterly financial report, nor is it an earnings release or proxy statement. It is a regulatory filing specific to material corporate changes. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document is lengthy (15,000 characters) and contains substantive information about the transaction, not just an announcement or a certification, so it is not a Report Publication Announcement or a certification filing.
2021-02-25 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that PsyBio Therapeutics Corp. has begun trading on the TSX Venture Exchange following the closing of a qualifying transaction involving a business combination agreement. It includes details about the transaction, the company's business, engagement of marketing services, and forward-looking statements. There are no financial statements, earnings data, or detailed financial analysis present. The document is an announcement of a capital market event (listing and transaction closing) rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or M&A filings. The content is primarily an update on financing and capital market status, specifically the commencement of trading and transaction closing. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and content support this classification with high confidence.
2021-02-25 English
Notice.pdf
Regulatory Filings
2021-02-22 English
Other securityholders documents - English.pdf
Fund Information / Factsheet Classification · 95% confidence The document is a detailed description of a financial instrument, specifically redeemable coupon notes linked to a Canadian insurance company index issued by Toronto-Dominion Bank. It includes terms of issuance, coupon payment conditions, redemption clauses, examples of calculation, and risk disclosures. The document is not a report of financial results, management discussion, or regulatory filing. It is a detailed product information document, likely a fund or structured product factsheet or offering summary. It is not an announcement or a brief summary but a comprehensive description of the product's features and terms. Given the nature and content, the best fitting category is Fund Information / Factsheet (FS).
2021-02-20 English
Other securityholders documents - English.pdf
Governance Information Classification · 95% confidence The document is titled 'Stock Option Plan' and details the purpose, definitions, administration, granting, pricing, and terms of stock options for PsyBio Therapeutics Corp. It is a detailed plan document outlining the rules and governance of the stock option program, including eligibility, restrictions, and exercise conditions. There is no indication that this is an announcement, a financial report, or a regulatory filing about a specific event. It is not a report of financial results, management discussion, or a proxy statement. The content fits the category of governance information as it details internal rules and governance practices related to stock options, which are part of corporate governance and compensation structure. Therefore, the appropriate classification is Governance Information (CGR). The document length and detail support a high confidence in this classification.
2021-02-20 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.